Newsroom

Clinical highlights: Spinocerebellar Ataxia - neuroClues

Written by Bao Nguyen | Jun 27, 2023 4:30:00 AM

Clinical highlights – June 2023

We are thrilled to inform you about the clinical benefits of eye tracking. Every month, we keep you updated on the latest news shared by the scientific community. The current newsletter will emphasize the latest research on Spinocerebellar Ataxia.

Enjoy the read!

The neuroClues® Team

 
 

Scale for Ocular motor Disorders in Ataxia (SODA) helps to follow up on disease progression

A consortium of neurologists was formed with the aim to design and validate a novel Scale for Ocular motor Disorders in Ataxia (SODA).

The primary purpose of the scale is to identify ocular motor dysfunctions in patients with cerebellar ataxia.

The researchers revealed in the study that the scale reliably measured the extent of saccade abnormalities and nystagmus.

Link to the publication

Eye movements in patients help differentiate across spinocerebellar ataxias

Researchers came to the conclusion that careful clinical examination of eye movements in patients with neurodegenerative disorders is an invaluable adjunct to neurological and cognitive assessments. Laboratory recordings of eye movements can provide valuable information about disease severity and progression. 

As reported in Table 1 below, eye movement abnormalities are common in patients with spinocerebellar ataxia (SCA) and reflect the combination of pure cerebellar degeneration and involvement of other brain regions. 

Link to the publication

 

Are you working on Spinocerebellar Ataxias and want to share you use case with us?

Do not hesitate to contact us and help share neuroClues* among your peers!